Samsung Bioepis ‘Setting A High Bar’ For Next Wave Of Biosimilars

Korea-Based Company Will Also Target ‘Value-Added Features’

 
• By Dean Rudge
  
Samsung Bioepis' Luke Oh spoke exclusively with GB • Source: viewimage/Shutterstock

More from Biosimilars

More from Products